2020-10-14

Press Releases Regulatory

Notice of extraordinary general meeting in 2cureX AB

The shareholders of 2cureX AB, reg. no. 559128-0077, (the “Company“) are hereby invited to the extra general meeting on Thursday...

2020-10-01

Press Releases Regulatory

Last patient successfully enrolled in the world’s first interventional trial with 3D microtumors as guide for choice of cancer treatment.

According to schedule, 2cureX’s clinical partner University Hospital Vejle today enrolled the last patient in the clinical validation study TICC1....

2020-09-14

Press Releases

2cureX launches world’s first CE-marked microtumor test service

CE IVD validated IndiTreat® launches today at the European Society of Medical Oncology (ESMO) virtual conference. 2cureX, pioneers in the...

2020-08-27

Press Releases Regulatory

2cureX AB (“2cureX”) hereby publishes the interim report for the first half of 2020

The half-year report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a...

2020-08-04

Press Releases

First day for trading in TO1 series warrants

As previously communicated, 2cureX AB (“2cureX” or the “Company”) has carried out a directed issue of shares and warrants of...

2020-07-13

Press Releases Regulatory

Record date for allotment of warrants of series TO1 is set to July 17, 2020

As previously announced, the board of directors of 2cureX AB (”2cureX or the ”Company”) has decided to distribute warrants free...